公开(公告)号：US20230194549A1

公开(公告)日：2023-06-22

申请号：US17918184

申请日：2021-04-08

申请人： BIOMÉRIEUX ,  BIOASTER ,  HOSPICES CIVILS DE LYON

发明人： François MALLET ,  Guillaume MONNERET ,  Virginie MOUCADEL ,  Alexandre PACHOT ,  Estelle PERONNET ,  Julien TEXTORIS ,  Fabienne VENET ,  Thomas RIMMELÉ

IPC分类号： G01N33/68 ,  G01N33/569

CPC分类号： G01N33/6866 ,  G01N33/56938 ,  G01N2333/31 ,  G01N2333/52 ,  G01N2800/26 ,  G01N2800/50

摘要： An in vitro or ex vivo method, based on the measurement of the expression of cytokine(s), from a patient's blood sample, incubated with a stimulus, for determining the risk of occurrence of a healthcare-associated infection in the patient, within seven days following the day on which the collection of the biological sample has been performed from the patient.

公开(公告)号：US20230250479A1

公开(公告)日：2023-08-10

申请号：US18014885

申请日：2021-07-05

申请人： BIOMÉRIEUX ,  BIOASTER

发明人： Laurence VACHOT ,  François MALLET ,  Guillaume MONNERET ,  Virginie MOUCADEL ,  Alexandre PACHOT ,  Estelle PERONNET ,  Thomas RIMMELÉ ,  Julien TEXTORIS ,  Fabienne VENET

IPC分类号： C12Q1/6883

CPC分类号： C12Q1/6883 ,  C12Q2600/118 ,  C12Q2600/158

摘要： An in vitro or ex vivo method for determining the risk of incidence of a care-related infection includes a step of measuring the expression of CD177 in a biological sample from said patient.

公开(公告)号：US20230220477A1

公开(公告)日：2023-07-13

申请号：US18014878

申请日：2021-07-05

申请人： BIOMÉRIEUX ,  BIOASTER

发明人： Laurence VACHOT ,  François MALLET ,  Guillaume MONNERET ,  Virginie MOUCADEL ,  Alexandre PACHOT ,  Estelle PERONNET ,  Thomas RIMMELÉ ,  Julien TEXTORIS ,  Fabienne VENET

IPC分类号： C12Q1/6883 ,  C12Q1/6813 ,  C12Q1/686

CPC分类号： C12Q1/6883 ,  C12Q1/6813 ,  C12Q1/686 ,  C12Q2600/118

摘要： An in vitro or ex vivo method for determining the risk of incidence of a healthcare-associated infection includes a step of measuring the expression of TAP2 in a biological sample from said patient.

公开(公告)号：US20230279492A1

公开(公告)日：2023-09-07

申请号：US18014814

申请日：2021-07-05

申请人： BIOMÉRIEUX ,  BIOASTER

发明人： Laurence VACHOT ,  François MALLET ,  Guillaume MONNERET ,  Virginie MOUCADEL ,  Alexandre PACHOT ,  Estelle PERONNET ,  Thomas RIMMELÉ ,  Julien TEXTORIS ,  Fabienne VENET

IPC分类号： C12Q1/6883

CPC分类号： C12Q1/6883 ,  C12Q2600/118 ,  C12Q2600/158

摘要： The invention relates to an in vitro or ex vivo method for determining the risk of incidence of a care-related infection in a patient, including a step of measuring the expression of CIITA in a biological sample from said patient.

公开(公告)号：US20240247312A1

公开(公告)日：2024-07-25

申请号：US18014801

申请日：2021-07-05

申请人： BIOMÉRIEUX ,  BIOASTER

发明人： Laurence VACHOT ,  François MALLET ,  Guillaume MONNERET ,  Virginie MOUCADEL ,  Alexandre PACHOT ,  Estelle PERONNET ,  Thomas RIMMELÉ ,  Julien TEXTORIS ,  Fabienne VENET

IPC分类号： C12Q1/6883 ,  C12Q1/6851

CPC分类号： C12Q1/6883 ,  C12Q1/6851 ,  C12Q2600/118 ,  C12Q2600/158

摘要： An in vitro or ex vivo method for determining the risk of incidence of a healthcare-associated infection in a patient, including a step of measuring the expression of at least one gene encoding a pro-inflammatory cytokine receptor located on chromosome 2 in the region 2q11-2q12, in a biological sample from the patient.

公开(公告)号：US20230313326A1

公开(公告)日：2023-10-05

申请号：US18014934

申请日：2021-07-05

申请人： BIOMÉRIEUX ,  BIOASTER

发明人： Laurence VACHOT ,  François MALLET ,  Guillaume MONNERET ,  Virginie MOUCADEL ,  Alexandre PACHOT ,  Estelle PERONNET ,  Thomas RIMMELÉ ,  Julien TEXTORIS ,  Fabienne VENET

IPC分类号： C12Q1/70 ,  C12Q1/689

CPC分类号： C12Q1/702 ,  C12Q1/689 ,  C12Q2600/158 ,  C12Q2600/118

摘要： An in vitro or ex vivo method for determining the risk of complication in a patient, including a step of measuring the expression of C3AR1 in a biological sample from the patient.

公开(公告)号：US20220333201A1

公开(公告)日：2022-10-20

申请号：US17764323

申请日：2020-09-25

申请人： BIOMÉRIEUX ,  BIOASTER ,  HOSPICES CIVILS DE LYON

发明人： Laurence VACHOT ,  François MALLET ,  Guillaume MONNERET ,  Virginie MOUCADEL ,  Alexandre PACHOT ,  Estelle PERONNET ,  Thomas RIMMELÉ ,  Julien TEXTORIS ,  Fabienne VENET

IPC分类号： C12Q1/6883 ,  G16H50/30

摘要： An in vitro or ex vivo method for determining the risk of occurrence of a healthcare-associated infection in a patient, including a step of measuring the expression of CX3CR1, in a biological sample of said patient.